Among these prognosis-associated genes, four genes, AHCY, CBS, DNMT3A, and MTAP (p-value < 0.05), were common markers of poor prognosis for neuroblastoma and breast cancer. This evidence concerns the gene DNMT3A and breast carcinoma.